VitaLink Research is a leading clinical trial research site business focused on performing Phase II – IV clinical trials for pharmaceutical companies and contract research organizations. These services include: patient recruitment, patient screening, as well as protocol specific testing, data collection and reporting. These are critical functions of the drug development process creating high demand for sites with access to a large patient database, a history of successful enrollment and quality data reporting. In 2017, VitaLink acquired Upstate Pharmaceutical Research.
Location: United States, South Carolina, Greenville
Investors 1
| Date | Name | Website |
| - | Great Poin... | gppfunds.c... |
Mentions in press and media 3
| Date | Title | Description |
| 12.08.2019 | VitaLink Acquires Comprehensive Clinical Trials | VitaLink Research announced that it has acquired West Palm Beach, FL-based Comprehensive Clinical Trials. CCT focuses on providing Phase II – IV clinical trials with a therapeutic focus in women’s health. The addition of CCT enables VitaLin... |
| 12.08.2019 | VitaLink Acquires Comprehensive Clinical Trials | VitaLink Research announced that it has acquired West Palm Beach, FL-based Comprehensive Clinical Trials. CCT focuses on providing Phase II – IV clinical trials with a therapeutic focus in women’s health. The addition of CCT enables VitaLin... |
| 17.10.2017 | Great Point Partners-backed VLR Acquires Upstate Pharmaceutical Research | Great Point Partners announced that VitaLink Research, a GPP II portfolio company, has acquired Greenville, SC-based Upstate Pharmaceutical Research. UPR focuses on providing Phase II – IV clinical trials with a respiratory therapeutic focu... |